See More StocksHome

PR

Permian Resources Corporation

Show Trading View Graph

Mentions (24Hr)

5

150.00% Today

Reddit Posts

r/pennystocksSee Post

$EQ Cash-Rich Penny Stocks Hedge Funds Are Buying - Equillium

r/pennystocksSee Post

$CVKD - Phase3 Bio stock -Will be on day 7 out of 10 to gain compliance this week.

r/pennystocksSee Post

CVKD - Bio - Phase 3 - 25 months Cash - No Debt - Keep watch on next week's catalyst.

r/smallstreetbetsSee Post

Lift Power Ltd (CSE: LIFT, OTCQX: LIFFF, Frankfurt: WS0) - Unlocking A Promising Junior Miner

r/pennystocksSee Post

$CBDW News out. 1606 Corp.'s AI Chatbot Generates Immediate Revenue Growth from New ISO Partnership

r/stocksSee Post

How do you guys research or find growth stocks?

r/pennystocksSee Post

1606 Corp (Stock Symbol: CBDW): A trailblazer in AI-driven merchandising chatbots

r/pennystocksSee Post

PharmaTher Holdings Ltd. ($PHRRF OTC)

r/stocksSee Post

Where should I invest in Index Fund/Mutual Fund: Canadian Stock Market Or USA's ?

r/investingSee Post

Where should I invest in Index Fund/Mutual Fund: Canadian Stock Market Or USA's

r/WallStreetbetsELITESee Post

IGPK insane OTC merger, JFH with 50M app downloads😳 DD inside!

r/WallstreetbetsnewSee Post

IGPK crazy OTC merger, JFH with 50M app downloads😳 (DD) *MUST READ*

r/pennystocksSee Post

IGPK craziest OTC merger, JFH over 50M app downloads *MUST READ* Research (DD)

r/pennystocksSee Post

$EQ Equillium - Unique pipeline: Acute Graft, Lupus, Alopecia

r/wallstreetbetsSee Post

Insider Sells on OpenDoor (OPEN)

r/wallstreetbetsSee Post

Trading McDonalds options based on the health status of Don Gorske

r/pennystocksSee Post

$CBDW News out. AI is gonna be huge in 2024 "1606 Corp. Accounts Skyrocket After December AI ChatBot Launch Leading to Expected Profitability in 2024"

r/pennystocksSee Post

$AEMC Unveils Promising Discoveries: High-Grade Nickel and Copper Abound in Nikolai Nickel Project

r/pennystocksSee Post

The whole IR _ versus _ PR thing

r/wallstreetbetsSee Post

Boeing Safety Crisis part 2 - why I give a damn and you should too

r/wallstreetbetsSee Post

RILY: Shorts are crowded, someone’s gonna get pounded

r/pennystocksSee Post

OTC Pink: CBDW PR 1606 Corp. CEO Attends Consumer Electronics Show (CES) For Collaboration Meetings

r/ShortsqueezeSee Post

VETCOMM Joins Prestigious Client List, Retains Premier Public Relations Firm BLAZE PR as It Readies for Marketing Launch

r/pennystocksSee Post

$CBDW News 1606 Corp. CEO Attends Consumer Electronics Show (CES) For Collaboration Meetings

r/wallstreetbetsSee Post

SPEC Anyone here in this? Carbon dioxide reduction company read article

r/wallstreetbetsSee Post

Unity3d laid off 1/3 of its employees realizing it invalidated all it's contracts & users don't even have to pay anymore. Bankruptcy future?

r/wallstreetbetsSee Post

Bitcoin Bros (like me) Dumb for Falling for the SEC Tweet

r/WallStreetbetsELITESee Post

Mining in Iceland with St-Georges Eco-Mining (CSE: SX) (OTCQB: SXOOF) (FSE:85G1)

r/wallstreetbetsSee Post

[DD] Here's what you're missing on the Boeing Safety Crisis

r/ShortsqueezeSee Post

$FSR HAS ITS OWN FORUM! Make a home for your favorite Ticker

r/pennystocksSee Post

ATOS - Summary PR

r/pennystocksSee Post

$NXGB NEWS OUT NxGen Brands, Inc. Proudly Announces the Successful Closing of "Mad House Innovations" Acquisition

r/smallstreetbetsSee Post

Mining in Iceland with St-Georges Eco-Mining (CSE: SX) (OTCQB: SXOOF) (FSE:85G1)

r/pennystocksSee Post

Equillium $EQ DD

r/ShortsqueezeSee Post

$CDIO PART 4 American Medical Association Grants Cardio Diagnostics A Dedicated CPT PLA Reimbursement Code For Epi+Gen CHD, An AI-Powered Test For Assessing The Probability Of A Heart Attack Or Coronary Heart Disease Event

r/ShortsqueezeSee Post

$MULN CTB 203% No volume this morning. PR to send it.

r/ShortsqueezeSee Post

$FSR - Reversal thesis still tracking beautifully (IMHO)

r/ShortsqueezeSee Post

Parazero $PRZO looking like shorts are crowded again watch for a PR drop to make them scurry again.

r/RobinHoodPennyStocksSee Post

BRSE updates Float/ Verifies Profile / Finalized Acquisition

r/pennystocksSee Post

$BRSE Updated Float Acquisition Complete

r/wallstreetbetsSee Post

Bitcoin ETF Will Actually Be Worse For Crypto

r/stocksSee Post

$IINN, is there good potential for FDA approval?

r/ShortsqueezeSee Post

SqueezeFinder Update - Dec 28th 2023

r/pennystocksSee Post

$SONX is no joke

r/wallstreetbetsSee Post

MARA MARA On The Wall You’re About To Lose It All

r/wallstreetbetsSee Post

Everyone Who Likes MARA Is Getting Coal For Christmas

r/pennystocksSee Post

$SONX - The Gift That Keeps on Giving (300%+ This Week)

r/ShortsqueezeSee Post

Might drop my FSR position. Thoughts?

r/pennystocksSee Post

$SAPX NEWS OUT Seven Arts Entertainment Announces Feature Film Production Agreement

r/investingSee Post

Need Investing advice, being an Immigrant in US

r/pennystocksSee Post

$TWOH CSE: $TWOH Older news but well worth considering when you combine it with how the company is positioning itself for 2024 and the Canadian food market.

r/pennystocksSee Post

Mining in Iceland with St-Georges Eco-Mining (CSE: SX) (OTCQB: SXOOF) (FSE:85G1)

r/pennystocksSee Post

Two Stocks Under $0.02 with a fundamental story: $CUBT and $VISM

r/WallStreetbetsELITESee Post

Anyone heard of African Agriculture?

r/ShortsqueezeSee Post

$PAPL EARNINGS RELEASED STOCK RISING

r/wallstreetbetsSee Post

Highly Regarded - Blackstone’s 2023 Holiday Video: The Alternatives Era

r/smallstreetbetsSee Post

Cell Signaling Technology Leverages Integrated Cyber's Employee-Focused Cybersecurity Service (CSE: ICS)

r/smallstreetbetsSee Post

Cell Signaling Technology Leverages Integrated Cyber's Employee-Focused Cybersecurity Service (CSE: ICS)

r/stocksSee Post

Why are Zara's stocks bullish despite a global backlash after a campaign backfired?

r/pennystocksSee Post

ABQQ One crazy stock DD inside *Must Read*

r/smallstreetbetsSee Post

TKVR Financials look like a dream, exciting business. Research (DD) *MUST READ*

r/smallstreetbetsSee Post

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023

r/pennystocksSee Post

Zomedica stock ready for a movement.

r/pennystocksSee Post

Cell Signaling Technology Leverages Integrated Cyber's Employee-Focused Cybersecurity Service (CSE: ICS)

r/ShortsqueezeSee Post

ARE THE BACK TO BACK $NEGG POSTS TAKING AWAY FROM OTHER POSSIBLE OPPORTUNITIES?

r/ShortsqueezeSee Post

$CYTO UP 180% STANDARD UP ADDITIONAL .12 AH @ .76

r/pennystocksSee Post

Will CAUD follow YOSH?

r/smallstreetbetsSee Post

NxGen Brands, Inc. Sets Out Strategic Vision for Growth in 2024

r/StockMarketSee Post

How to determine the starting price of a triangular reverse merger? Are any current examples in the stock market?

r/stocksSee Post

How to determine the starting price of a triangular reverse merger? Are any current examples in the stock market?

r/ShortsqueezeSee Post

$SONG UPDATED BULLISH NEWS (follow up from initial post)

r/smallstreetbetsSee Post

$TLIF on news watch

r/ShortsqueezeSee Post

A bullish case (w/DD) for Fisker FSR (SI: 41%)

r/pennystocksSee Post

TKVR (DD) *Must Read* Financials look like a dream

r/smallstreetbetsSee Post

TMGI ~ from yesterdays PR.

r/pennystocksSee Post

Red Flag: Put your money somewhere other than Mullen Stock.

r/wallstreetbetsSee Post

Unpopular opinion: Elon Musk buying Twitter was a genius move

r/ShortsqueezeSee Post

$WIMI .6302 Interesting Read and Possibly Long Hold

r/pennystocksSee Post

Surge Battery Metals ($NILI) Announces Insider Buying of 500,000 Shares, Reassuring The Market 🚀

r/ShortsqueezeSee Post

POSSIBLE BREAKOUT: $SONG just had more than half of its OS removed. CEO posted that an official PR is being is released tomorrow morning at 8am. Plus the price just broke past a major resistance from an all time low!!! Enterprise Value $106,649,000. View post for images of Chart 1D, 5D, 1M, 1Y

r/pennystocksSee Post

$INKW News dropped. Great PR here. Greene Concepts Prepares for Banner Year in 2024 and Company’s Highest Growth Levels

r/pennystocksSee Post

MBRX - Moleculin Presents Positive Preliminary Efficacy Findings from Phase 1B/2 Clinical Trial Demonstrating 64% Stable Disease Rate Through Two Cycles of Annamycin for the Treatment of Soft Tissue Sarcomas (STS) Lung Metastases

r/pennystocksSee Post

$TWOH News out. Two Hands Corporation Launches Sports Illustrated Line Protein Bars in Canada

r/pennystocksSee Post

CDIO looks good

r/pennystocksSee Post

🚀🌑 XXII Calls: The Menthol Maverick Move? 🚬💨 FDA Drama & Strategic Shuffling Ahead! 📈

r/wallstreetbetsSee Post

Cole Capital offers $9 per share for WE. Stock shoots up 140% AH on Friday. 30 mins later multiple news websites pull the PR for "fake".

r/wallstreetbetsSee Post

Cole Capital offers $9 per share for WE after market close on Friday. Stock shoots up 140% and then falls as PR gets pulled for being “fake”

r/stocksSee Post

UAW has Tesla, Toyota in its sights after contract wins at Detroit automakers

r/wallstreetbetsSee Post

$TEVA - DD inside

r/ShortsqueezeSee Post

$LMDX patent news! Official PR should be soon

r/pennystocksSee Post

$LMDX patent news! Official PR should be soon

r/pennystocksSee Post

$CBDW News dropped midday. 1606 Corp announces cutting-edge AI-driven ChatCBDW will launch on Tuesday

r/pennystocksSee Post

$INKW NEWS Be Water Receives Coveted Golden Ticket Award At Walmart’s Open Call 2023

r/ShortsqueezeSee Post

ICU SeaStar Medical SQUEEZING Monday Oct 30th 2023

r/ShortsqueezeSee Post

APLM has a warrant price Target of 11.50 as of Sept 29th

r/pennystocksSee Post

$APLM is OFFICIALLY a shortsqueeze play. Warrants exercisable at a price of 11.50 per share. At time The PR was posted APLM priced at $4. APLM has earnings coming on November 7th. Analyst price targets of $17-24.15 per share. Institutions Own 17.04% of the Float and is 58.47% held by Insiders.

r/pennystocksSee Post

$APLM is OFFICIALLY a shortsqueeze play. Warrants exercisable at a price of 11.50 per share. At time The PR was posted APLM priced at $4. APLM has earnings coming on November 7th. Analyst price targets of $17-24.15 per share. Institutions Own 17.04% of the Float and is 58.47% held by Insiders.

r/pennystocksSee Post

$CBDW NEWS OUT. 1606 Corp. Provides Development Update on ChatCBD

r/WallStreetbetsELITESee Post

Anyone know anything about Anixa $ANIX

r/pennystocksSee Post

$TCBP - TC BioPharm Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AML

Mentions

PSTV itself need a good PR dept. to address this. Unfortunately, its non existent. Their reddit is mostly repost of thread from other Redditors like u/Freedom5567

Mentions:#PSTV#PR

Imagine having Vance as temp president my god PR between countries would be fucked

Mentions:#PR

Lol why are you when running positive PR for this guy? When he got fired for it.  Why don't he fuck his wife instead of fucking his employees? My comment doesn't warrant an edit because this guy was still willing to ruin his life for some illegitimate sex.

Mentions:#PR

How does your algo “signal[s] when they are possibly leaking that their BS “PR campign” will start” based on technical and fundamental analysis?

Mentions:#PR

Today’s plan: - wake up drink electrolytes 20z, meditate. - read the Bible - swipe on tinder age range 18-55 (30 min) - inject steroids in ass - gym chest PR day, 40z water. - assess all the milfs you’ve matched with, while protein maxing post workout - track daily steps/walk the dog, meditate. - smash someone’s mom from tinder - confession for all the sins committed - sleep at 7pm to make sure you get 8 hours for circadian rhythm health Repeat

Mentions:#PR

CGTX, let’s have a great week! Hope for PR on Tuesday pre-market

Mentions:#CGTX#PR

I do invest solely in penny biotechs, especially late stage phase 2+3 bios. You can easily tell which ones are good and which ones are bad by reading their own PR, and interrogating past clinical trials of the same drug when available, or their own phase 2+3 data when they've published it. The only ticker at this time I'd say is a good play is SLS. Their phase 2 clinical data was published here: [https://pmc.ncbi.nlm.nih.gov/articles/PMC5812332/](https://pmc.ncbi.nlm.nih.gov/articles/PMC5812332/) Demonstrating a huge increase over placebo for overall survival rate. Will it make it through phase 3? I'd say there's a good chance, but to be realistic phase 2 clinical results can fail to be repeated in phase 3. It happens. You have to be realistic about these things that while I think it's a good bet, nothing is guaranteed. I am not promising the moon or incredible valuations, that will come after phase 3 demonstrates that it meets its primary endpoint which is increased overall survival rate. You also have to take into account that passing phase 3 is itself not a guarantee of receiving FDA approval. If they don't feel the data is good they'll issue a clear response letter which kills the whole thing because it means that SLS would have to repeats its phase 3 trials. So I would say it's a smart play. There's no shell game being played with their PR where they point to irrelevant statistics as being excellent. The phase 2 clinical trial was published in a timely fashion showing the outstanding results.

Mentions:#PR#SLS

PR latinas are mid, they’re just American girls Buy Colombia for the real latinas

Mentions:#PR

It’s new. Says it right in the first sentence. It’s a material development and would need be PR’ed obvi…. *Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has established a **new** at-the-market equity program (the "ATM Program") that allows Canopy Growth to issue and sell up to US$200 million of common shares of the Company ("Common Shares") from treasury from time to time in concurrent public offerings in the United States (the "U.S. Offering") and Canada; provided*

Mentions:#PR#WEED#CGC

But, how low *is* low IV? There’s a market-wide IV and a stock IV. I heard this before but never really seen it until after Apple earnings. If you look at far out Apple $260 strike for March 2026 and check how low it went on August 1st, you’d find my entry point. This was both the day Apple first opened after earnings (after hours the Thursday prior) and the day the market dropped to 620 because of tariffs resuming. I loaded up on 20 Apple calls at the above expiration and strike for a premium of 2.35 each. Within a week they’re worth over $800 each. I did sell before it hit $800 to just grab a quick profit, but this is a perfect example of extra low IV being unbeatable on high volume stocks as well illustrating your last point about holding if it may go up more… because when I sold Apple had shot from 201 to 208. The day after I sold their CEO made an announcement about investing in infrastructure in America and visited Trump giving big PR and leading it higher to 230, but unless you knew the future, it wouldn’t have made sense to hold out for that. Granted, my original idea was to sell half at double to guarantee no losses. Moral of the story: stick to the plan.

Mentions:#PR

Such a silly and unprofessional way to demonstrate that you shouldn't be a PR team member or, God forbid, a c suite member. Informal talk, vague statements and borderline trolling. You don't even have a website, nor can you give us any meaningful information beyond "ya were projected to make 10m" You seriously think you'll find investors this way?

Mentions:#PR

In one year it will still be a bad play, so I don't need to check? The science itself, the metrics they've pushed as their big wins in the PR from their own phase 2 readout, clearly state why. This thing will make it through phase 3, but it will not get FDA approval for lack of efficacy over current treatments. No drug is considered in a vacuum and this one underperforms vs placebo, god only knows what a head to head against CPAP machines would produce.

Mentions:#PR

People, I've got two takedowns for you here: FBIO is not gonna moon, they're burning cash like crazy getting those subsidiaries up and into phase 2+3. Hypothetically could they be worth a fortune one day? Sure, anything can happen. As is, they will remain a penny bio play until they sell their interest in Journey Medical Corporation for a handsome sum in a buyout. Which, that could actually happen, so you should buy journey instead you'll get more upside and not be in a pharma incubator that is burning cash constantly and unlikely to return long term gains till all of its pipeline reaches maturity and gets sold. Can you wait years upon years for that to happen? If you're in this sub probably not. NRXP has repeatedly failed to show significance in its trials. The thing you have to understand about phase 2/2b studies is that they can give you insight into how well a drug performs even if the overall function is to find safety and dosage for a given treatment. If the dosage they're taking into phase 3 has no great difference over placebo or other drugs used in the study as a baseline measurement then the dose is worthless. That dosage is supposed to be what they're building their entire phase 3 and new drug application around. The primary metric they pushed was a 90%+ reduction in akisthesia. That's nice, great. It's supposed to be treating suicidal depression as it's primary endpoint though so it means nothing. Do not let them flim flam you. In the case of NRXP they've built this entire narrative about ANDA and FDA fast-track. The thing you have to realize is that an ANDA just says their generic form of a drug performs the same as the regular kind. This is nothing. An FDA fast track also, unfortunately, means nothing. Over half of all drugs with a fast track designation will fail. As well NRXP's repeated PR releases about the dangers of Benzethonium Chloride are pure fearmongering. You know why it was taken out of soaps? Because in large concentration it's a skin irritant. They're sitting there putting out these PR releases thinking you won't double check their statements or look behind the curtain. Yet one more PR of theirs designed to inflate the importance of their drug.

Mentions:#FBIO#NRXP#PR

Yeah the guy, the founder lives in New York! So nothing big including their regular PR game. This is what they always do… :)

Mentions:#PR

HIMS puts of 42.50; successful. Now waiting for Lulu puts 200 and ONON calls 48. 9/15 & 22. (Anything in within 1.50/2 seems feasible. HIMS I chose because it's been overvalued for some time. Still is. They need to shift and focus to HERS. Women are more loyal in the health and beauty market, but I think the weight loss drugs are about to hit bad safety PR. ONON, also has been overvalued, but around 45 is a good entry point for long term. Tariffs won't have as much damage as others because their market does not really care. They have a loyal high value, international following, sponsoring players in sports like Tennis and Track and Field. All Tennis Majors are a big commercial for them. We are not at the U.S Open. They have the World Track competition in Tokyo, that will extend the brand. They will grow steadily, hitting the sweet sport by the Olympics. Lulu is way overvalued. In a way, the are the Tesla of leisurewear. There is no reason for them to be this high, but people are propping them up. That can only last for so long. They tried to expand internationally on a large scale, but that won't help their numbers. Usually by the time clothing firms try to do that, it's already too late. Plus, I don't believe their financials. It's giving WeWork to me. Lulu Delulu will be the name of their future Netflix docuseries.

Mentions:#HIMS#ONON#PR

This stock is garbage. People please do not buy it. For your own sake. The reposa phase 2 trials PR says it all. They used AHI as their lead metric to show "efficacy". AHI is not a meaningful metric because there's no actual scientific methodology behind counting apneas per hour. The rest of the metrics they decided to push in the PR were garbage quality of life things. If I have cancer and your pill improves my quality of life but doesn't cure my cancer when it is meant to then what exactly was achieved? There's no universe where this stock stops being garbage entirely because the science itself doesn't support that. Do not let other people trade on your ignorance.

Mentions:#PR

I own it, Duolingo’s valuation is stretched. There’s been pressure from Google and OpenAI are apparently encroaching on their territory. I think this will be interesting because Duolingo hasn’t had to face off against any serious competitor yet imo. If they can repel Google and OpenAI that gives me more confidence in the company. Luis is a smart ceo but he needs to learn not to say too much. He really pissed off users and it was bad PR. Duolingo has a hundred million users so there are network effects but Googles is even bigger. I’ll be watching to see if management can navigate through these challenges. Duolingo is also expanding into other subjects as well like chess and math. Duolingo needs to increase their engagement time on their platform and then monetize it with subscriptions or ads. I invested into them because I believe they can be like Spotify and Netflix. But Duo has to prove themselves and show they can fend off the real superstars. If they can’t then the bears and naysayers will be right.

Mentions:#PR

I'm so skeptical on the robot hype. At least how they are being sold via PR. AI simply won't work in that format with how they are being sold, and you either have a specialized use case for them (like manufacturing X widget) or you don't. If it's specialized you just build a specialized robot. If your use case isn't specialized, these things aren't happening until locally run AI programs get A LOT better.

Mentions:#PR#LOT

Company news & PR articles https://www.bioxceltherapeutics.com

Mentions:#PR

Im starting a similar company called Scoots Scoop n Poop. Scoot scoops poop out of yards.  I don't know anyone named Scoot, but I plan to find a convicted felon down on his luck and use him as my poster boy. He'll be Scoot. Then we'll hire other felons also down on their luck and scoop more poop with scoot and co. Eventually we'll hit it big til Scoot gets back to his dastardly ways and the whole company goes under from the PR nightmare.  I miss you, Scoot. Come scoop poop?

Mentions:#PR

I mean they have till October to reach compliance, I'm not sure they've got enough PR to make it unless the buyback pumps it up in itself? Fantastic products, dumbass management

Mentions:#PR

**$AIRE** : Short float: **15%**(most likely) - 65% getting mixed results since last update was 2 weeks ago(Fintel,Finviz,market beat,Yahoo), short ratio: 0.35 ratio, short interest 7.1M. RV 0.5. (Finviz). Watch for volume. (15% + AH, trending). Not a long hold looking for momentum. Recent Expansion PR Aug 27: https://finviz.com/news/151614/realpha-expands-homebuying-platform-into-georgia-activating-third-state-in-national-realty-rollout **RISKS** : Oct 8meeting(Dilution/RS vote). : https://www.sec.gov/Archives/edgar/data/1859199/000200858925000054/realpha_def14a.htm

Mentions:#AIRE#PR#RS

Apple Just Locked Up Half of TSMC’s 2nm Chip Supply — Here’s Why It Matters for Investors Apple has reportedly secured nearly 50% of TSMC’s 2nm chip production — the most advanced node expected to power iPhone 18. The kicker? These chips will be packaged in the U.S. (TSMC’s Arizona plant), meaning Apple may effectively bypass the proposed 100% chip import tariffs under a second Trump administration. This could have major implications: • Supply chain moat vs. Samsung/Google • Tariff insulation = protected margins • Early access to 2nm = iPhone performance lead • AAPL’s $600B U.S. investment is no longer just PR — it’s strategic Stock hasn’t fully priced this in yet, IMO. Keep an eye on this going into iPhone 18 launch + earnings. Sources: Benzinga, TSMC US investment background

Mentions:#AAPL#PR

He could do PR for the White House or Trulieve. Apparently neither do background checks or cares about prior nefarious activities.

Mentions:#PR

No, November. Check latest PR.

Mentions:#PR

A nice PR dropped a couple days ago but other than that it’s basically dead. Saw a ton of volume relatively the last couple of days. When she wakes up she runs HARD

Mentions:#PR#HARD

It’s really kind of funny considering he talked about turning Gaza into a tourist bastion or whatever. You could pump money into PR and see real returns.

Mentions:#PR

$CGTX, Here’s my take on the dilution news. While it’s not as bad as an ATM offering, it’s still not the most positive development in the short term, especially for retail investors’ sentiment. That said, it alleviates the major fear retail investors had about a heavy ATM offering, which is common among many companies at this stage. The timing of the announcement was strategic, giving investors enough time to digest the news, evaluate it, and decide whether to hold, sell, or add shares. Through the RDO, outstanding shares will increase by around 20%, and the share price in the deal seems to be over $2.04 (as mentioned in the PR, where $30M is raised after deducting fees, etc.). Moreover, securing such significant funding indicates strong confidence in the company’s future. Kudos to the management team for handling this so well. It also appears that two Vanguard funds bought about 1.3M shares yesterday. Shareholders can analyze the implications and decide how to proceed with their investments.

Mentions:#CGTX#PR

There should be some nice PR coming in Sept. to give the recovery a boost.

Mentions:#PR

Since the reading comprehension skills in the chat are not that high, here's the more important part of the CGTX PR: The offering was made to two new fundamental institutional investors, including a preeminent global investment manager. It's not for the regards like you, it's for Vanguard. Disc: I'm not in, I don't care.

Mentions:#CGTX#PR

He should just allow PR in

Mentions:#PR

#breaking: jensen has hired sydney weendyes big tetas to do some PR damage after stock drop AH

Mentions:#PR

Unbelievable XIV's PR team didn't lock down this alt. But it'll be funny as hell when the OpenAi LLMs are trained on your comments. Go forth and multiply dude. 😆😂🤣

Mentions:#PR

$nvx. Curious if the PR moves this up. It seems like a big deal seeing how RFK and Trump are banning other COVID shots. https://ir.novavax.com/press-releases/2025-08-27-Novavaxs-Nuvaxovid-TM-2025-2026-Formula-COVID-19-Vaccine-Approved-in-the-U-S

Mentions:#PR#TM

This bill does not close the loophole. It legitimizes hemp products actually. And this PR misrepresents what the bill says - which is exactly in their playbook. No bueno.

Mentions:#PR

I'd be surprised if some tutes or big investors don't jump in, now that it is compliant. Yesterday would have been a good day for them to invest, but the official compliance PR was at the closing bell. With huge BTD PR coming any day now...

Mentions:#PR

Ok, got ya. The kitchen table PR spin.

Mentions:#PR

CEO need a few lessons about PR.

Mentions:#PR

CGTX compliance PR just dropped!

Mentions:#CGTX#PR

I would love to see CTM put out some PR

Mentions:#CTM#PR

SATS is already up over 40% premarket… Source: PR Newswire https://www.prnewswire.com/news-releases/echostar-announces-spectrum-sale-and-hybrid-mobile-network-operator-mno-agreement-steps-toward-resolving-federal-communications-commissions-fcc-inquiries-302538317.html

Mentions:#SATS#PR

I think it's a good method to maintain investor confidence while also having the best shot at maintaining compliance by pushing it above $1. Their product is doing VERY well in the clinical trials, leadership has called out the market manipulation directly, and they reportedly have more than enough needed for Phase 3. The buyback creates more demand for shares, and it's a solid PR move to show the company believes in what it's doing. It isn't enough for a full-on short squeeze, more than likely, but it's a fantastic signal if you're looking for a long-term investment.

Mentions:#PR

Respectfully, those stats are not very squeezy. Also those metrics are useless without the complete information: **10%** short float and **0.06** short ratio is minimal. It’s running on a fluff PR and retail hopes : (Aug 22) : 20M **Authorization** of shares repurchase anytime in the future, maybe , just trust me bro(CEO). : https://www.sec.gov/ix?doc=/Archives/edgar/data/0001873875/000121390025079600/ea0254125-8k_incannex.htm Money definitely can be made here but this post is misleading and full of hopes. Good luck OP hopefully it climb above 1$ and you can break even.

Mentions:#PR

Puts seemed like easy money last week. I'm down the same. I'm hoping the market tanks this week and drags it with it. Or some bad PR drops asap.

Mentions:#PR

On PR duty today Mike?

Mentions:#PR

It would be nice if we could reach 6 to 7 before any PR, for maximum potential.

Mentions:#PR

Those commitments are mostly PR, either projects approved years ago (in Apple's case) or proposals that can easily be modified when the political or economic winds change.

Mentions:#PR

i hear you! there are so many things in the works right now, and anyone long just needs to be patient for when the PR's hit, and people will realize why ROOT will be larger than PGR one day

Mentions:#PR#ROOT#PGR

im a mega ROOT bull, but i would actually chill with the AMZN/HERTZ rumor until we see an actual PR. if its true, it would be one of the biggest announcements out there.

Mentions:#ROOT#AMZN#PR

It's so hard to predict this stock. It has it's days where it just sits and goes sideways and days where it goes 40%+. And this week is going to be super unpredictable, because we don't know exactly when the PR will drop. I mean, if no PR Monday, it may go up 15% and sit there all day. It may get a fomo surge and rise 40% again. If good BTD PR, 100% isn't out of the question.

Mentions:#PR

What order do you think the PR will be in? I'm thinking like this. 1. Compliance 2. BTD 3. Partnership

Mentions:#PR

This thing is going to absolutely fly this week. Compliance and possible BTD PR. Many are predicting a possible 100% in 1 day this week. Just saying. https://preview.redd.it/fl8j8kw782lf1.png?width=976&format=png&auto=webp&s=496b318bcca87f7497f97aa81822c0d8800bc3c6

Mentions:#PR

I’ll add my personal prediction, since that’s really all this is. Just everyone’s best guess. RBLX shares will more than double over the next 12 months. They will increase by more than 50% within the next 4 months. I sell weekly CSP’s on RBLX and own long shares, which are currently up 25% or so. Every major platform has dealt with a “predator” type situation, or worse. YouTube, especially, has had its PR problems over the years. It always comes through unscathed and bigger/better than ever. RBLX has extremely good parental controls. They work when they’re used, and they’re always used unless a child proactively lies about their age. Also, RBLX is unique and ubiquitous for kids ages 6+. My kids used to prefer receiving Robux to getting actual money. The “Grow a Garden” game is so crazy popular right now that it temporarily shut down the server just a couple days ago when an event was taking place. Next earnings and guidance will impress. We shall see.

Mentions:#RBLX#PR

I mean, its not just good PR.... its actually just a good thing. It's not like it's some bait and switch where your 401k just LOOK better, it is better. Can it be used to say "look at this good thing I did"? Sure. But it is good.

Mentions:#PR

Thats good PR though. Its beneficial for both the public and google

Mentions:#PR

Alphabet, and Google itself, is more than capable of doing many good things while managing a host of evil ones as well. Many companies sponsor Free Software projects, and certainly I’d love to see it more. Almost all of those arrangements have some degree of likely benefit to the sponsor down the line, or otherwise a clear PR win at least. This is easily and shrewdly afforded as part of a wide R&D spend. Google as one of the dominant sellers of Web services is heavily incentivized to focus on open source software that improves your connection to those services or reduces their cost maintaining them. All is in service of deploying those services as widely as possible, and attracting as little antitrust attention. In the position they’re in, where their competitors benefit, Google usually benefits more. None of this is a problem. It’s just more of a smart investment than a shield of virtue.

Mentions:#PR

BTAI top line data coming next week Just double checked and they normally give PR on Mondays or Thursdays.

Mentions:#BTAI#PR

People need to learn that nothing bad is going to be announced that makes Americans mad when Pres T sentiment is already down. If his sentiment was positive at the moment he would have let the pullback happen…. But if he’s already got eyes on him and negative stories he’s going to always make sure there are other positive news going on to draw eyes away from that. Epstein, tariffs, war, etc. he’s absolutely going to keep people happy with the markets and have reporters and others boost those stories. Fear a pullback when his sentiment on everything else is high and then he will risk a planned pullback. It’s PR and it how it works, in my opinion. It may sound conspiracy theorist or whatever but the truth is that we do not know 1/10th of what happens in our country and we are not told the truth about anything outright. Bad news, they misdirect our attention elsewhere. Something big going on that they want focus away from, give them something else to focus on…. They would never risk Americans losing retirement and investments at a time where sentiment from Epstein, the BB BILL, Israel, etc. is all going on. They need to keep us happy in some way. It’s a rule…. We are controlled by a few hundred powerful people with imaginary lines that only exist in our minds and there are millions of us…. It’s a delicate balance… they have to keep us distracted and happy enough to keep us within those lines, laws and boundaries, but also keep us fearful, separated, and helpless enough that we rely on them. Without this delicate balance the citizens could realize they had enough and overthrow government at anytime be sheer force and numbers. The other way keeps us working for them while they reap the rewards…. They aren’t going to disrupt the balance and if it is there is probably a crisis so big/bad it outweighs the sentiment. For example COVID…. So much could wrong during COVID because people were worried about their actual lives and not wanting to die and not about how are my kids going to afford college or will I make to my kids graduation? I know people worry about crashes and things but it takes a lot to crash a market and if it does happen it will be planned, there will be signs and it won’t be a few numbers up on a sheet of paper.

Mentions:#PR#BB#BILL

That was just PR to get elected now that they are in power you see their true motives

Mentions:#PR

Rklb and asts dropping PR after hours. Seems like they really want to keep the race back to 50 interesting next week

Mentions:#PR

This is from an August 6 PR from Events: "[Events.com is preparing for its potential public debut following its previously announced business combination](https://www.prnewswire.com/news-releases/eventscom-and-summit-merge-to-create-a-powerful-platform-that-expands-the-global-creative-business-economy-302522892.html#:~:text=is%20preparing%20for%20its%20potential%20public%20debut%20following%20its%20previously) with Concord Acquisition Corp. II (OTCQX: CNDA), a publicly traded special purpose acquisition company, which is expected to close in 2025, subject to the satisfaction or waiver of customary closing conditions. The combined public company ("PubCo") is expected to be named "Events.com" and to list its common stock under the new ticker symbol "**RSVP**," subject to the approval of its listing application." CNDA has until December 31 to complete the deal, extend, or liquidate. It doesn't look like Events.com or CNDA have filed a SEC registration statement for the deal, which was announced one year ago. That's not a great sign.

Mentions:#PR#CNDA

$EDUC - good PR. seems low at $1.20. This can move up today and next few days. Check it out boys and girls

Mentions:#EDUC#PR

Dude, I held it and accumulated since late April and sat through all the good PR, while it hovered around .20. My average was .21. Then I doubled up when it was like .40s to bring my average to .29. Then I bought more way after that to bring my average to \~.40. Watched it go to 1.73 or so on the magical day. Down to 1.50. It's going back up right. 1.40. It's going to skyrocket any minute. 1.30. Finger on the sell button. The opening bell rings. 1.20. I'm sorry ole girl, but I got to pull the trigger.

Mentions:#PR

IF you have been following BTAI: 1)you know they will release the top line data during August. 2)they did not need to have the sNDA meeting with FDA as they met all the requirements (bullish) 3) they openly already thanked the research team for the work 4) strong positive tone in the PR and live conference calls 5) they locked the data last Monday and it takes at least 1 week (typically 1-3 weeks) to process it and release it, but they have several time mentioned “during august” 6) they release data typically Mondays or Thursdays Meaning. IF believe they will have good Top line data you have only few days to react. It will have an impact to stock price. Not financial advice. You can find all this from BTAI press releases or ask ChatGTP.

Mentions:#BTAI#PR

With good PR and volume it will fly with current stats, if no PR by end of August i will exit my cb is 1.50

Mentions:#PR

Honestly I can speculate about “180 day extension possible PR” that can serve as a catalyst to send it, or after hours RS announcement tomorrow. Can also be complete silence. Still heavily shorted and no news drop is odd I was not expecting it, I’m gambling here. But truth is nobody knows, it’s to risky to enter IMHO can go ether way I entered the “dip” at 0.088ish and average down after it bottomed out. Ether way I’m out tomorrow.

Mentions:#PR#RS

I sold my 1/1/26 calls today at 100% gain, had to much invested in it to gamble. Bought some puts for leverage , still holding all the shares for PR. High hopes here just don’t want to be priced in.

Mentions:#PR

That's pretty reasonable ngl. The 55-mile piloted flight is a legit milestone, shows they’re not just doing PR stunts but actually putting Midnight through its paces. The $1.8B in cash gives them cushion, but the real test is how fast that burn goes while waiting on FAA. If they can keep pace on defense deals with Anduril, that could be the bridge that funds them through. I’d build in chunks like you said, don’t rush, but don’t sleep either

Mentions:#PR

Another day, another pump for High Tide. High Tide must use the same PR firm as that no talent Sidney Sweeney.

Mentions:#PR

Jumped last Friday, has been trading sideways ever since. waiting for a PR to spike the volume we need to shoot this back to $1

Mentions:#PR

1. Release of a PR statement detailing official minutes from the End-of-Phase 2 (EOP2) meeting, confirming FDA alignment. (Occurred - PR statement better than expected) 2. Federal Reserve rate cut could drive market fund inflows, potentially boosting CGTX. 3. PR announcement confirming EOP2 meeting is scheduled with FDA for DLB. 4. PR announcement confirming a successful EOP2 meeting for DLB and that CGTX and FDA are in alignment (Unofficial) 5. FDA grants BTD for CGTX’s DLB treatment, signaling strong regulatory support. 6. Confirmation from NASDAQ that CGTX has met the $1.00 listing requirement before the deadline. 7. PR statement outlining official minutes from the DLB EOP2 meeting confirming FDA alignment. 8. CGTX announces a strategic partnership agreement. 9. Launch of Phase 3 clinical trials for Zervimesine in AD and DLB. 10. Release of positive interim data or progress updates from ongoing clinical trials.

Mentions:#PR#CGTX#DLB

Likely earnings this week and PR about the decision on the €12M grant requested by the end of the month. Grant is the last thing missing to proceed with 100% acquisition of an Italian biotech.

Mentions:#PR

Because he is now the most hated man in America. He probably only tamed the bad PR because it started hurting financially

Mentions:#PR

# TL;DR * **No scheduled company-specific catalysts before 8/22** (earnings are **Thu 8/28 after close**), so there isn’t a known event timer between now and your expiry. [Yahoo Finance](https://finance.yahoo.com/news/webull-release-second-quarter-2025-190000892.html?utm_source=chatgpt.com)[MarketChameleon.com](https://marketchameleon.com/Overview/BULL/Earnings/Earnings-Dates/?utm_source=chatgpt.com) * **Lockups:** the big ones **don’t hit this week**. Most existing Webull shareholders are locked **180 days from close (Apr 10 → \~Oct 7, 2025)**; a **discretionary early release (up to 25%)** only *opens* **≥150 days post-close (\~Sep 7)** if price conditions are met. SPAC/sponsor pieces have **1-year** locks. [StreetInsider.com+1](https://www.streetinsider.com/SEC%2BFilings/Form%2BF-1%2BWebull%2BCorp/24722190.html?utm_source=chatgpt.com)[SEC](https://www.sec.gov/Archives/edgar/data/1912461/000121390025031274/ea0238129-8k_skgrowth.htm?utm_source=chatgpt.com) * **Warrants overhang:** the special **incentive warrants were redeemed June 30** (20.45M exercised → \~$204.5M raised). That wave is **already behind us**. [SEC](https://www.sec.gov/Archives/edgar/data/1866364/000121390025061373/ea0248030-6k_webull.htm?utm_source=chatgpt.com)[Barchart.com](https://www.barchart.com/story/news/32627634/webull-announces-redemption-of-incentive-warrants?utm_source=chatgpt.com)[NASDAQ Trader](https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-284&utm_source=chatgpt.com)[StreetInsider.com](https://www.streetinsider.com/Corporate%2BNews/Webull%2BCorp%2B%28BULL%29%2BAnnounces%2BRedemption%2Bof%2BIncentive%2BWarrants/24866441.html?utm_source=chatgpt.com)[Seeking Alpha](https://seekingalpha.com/article/4798569-webull-corporation-breakout-warrants-appreciation?utm_source=chatgpt.com) * **Capital overhang:** on **July 1** Webull signed a **$1B standby equity purchase (Yorkville)**. Sales under it **require an effective resale F-1**, so **drawdowns are discretionary** but possible once effective—this is an **ongoing dilution risk**, not a dated 8/22 catalyst. [SEC+1](https://www.sec.gov/Archives/edgar/data/1866364/000121390025061373/ea0248030-6k_webull.htm?utm_source=chatgpt.com)[PR Newswire](https://www.prnewswire.com/news-releases/webull-announces-1-billion-standby-equity-agreement-302497054.html?utm_source=chatgpt.com) * **Right now the $15 put is ITM:** spot was \~**$14.35** today—**assignment risk is high** unless the stock pops back over $15 by Friday. **IV is elevated (\~97%)**, so **gamma will be spicy into expiry**.

Mentions:#PR

**$SCNI** has a float of 0.8M and 33% short float. Expected acquisition grant PR August. Will not stay past EOM.

Mentions:#SCNI#PR

TLPH looking good today, they should PR a milestone for patient enrollment anyday now

Mentions:#TLPH#PR

Oh yeah very true. My point being that Costco is now clearly the #1 spot to overspend with no guilt in a retail environment (based on perceived value) and it took a while for that shift to be fully realized. Coupled with the PR disasters on social issues and proliferation of same day delivery, you have a perfect storm for target to be in a difficult spot.

Mentions:#PR

I’ve read the wiki/FAQ — looking for practical advice. I’m 28, Turkish citizen on an Estonian TRP tied to my job (may need to move to Turkey or Ukraine). Net worth ≈ €54k (\~€36k savings, €4.5k IWDA/EIMI — both accumulating, rest cash). I save \~€2k/month (I’m extremely frugal — monthly expenses €1k; I save \~70% of net salary) but that stops if I lose the job. No debt. I’ll keep at least €25k as emergency savings. I’m considering putting €20k more into IWDA and leaving it for at least 5 years. Time horizon for buying a home: Estonia 5–6 yrs (if PR), Turkey 5+ yrs, Ukraine 5 yrs. I’m conservative and prefer capital preservation. Should I keep building ETFs long-term, aggressively save for a house I might not live in for 10+ years for case of Ukraine/Turkey, or keep everything liquid for sudden relocation? Practical, low-effort plans appreciated.

Mentions:#TRP#PR

* Accumulate only in *quiet, forgotten phases* (low chatter, low volume). * Sell aggressively into defense-related hype (cyberattacks, Taiwan flare-ups, “homeland security” contracts). * Avoid post-PR holding — dilution almost always follows * **Entry Zone:** Thin-volume accumulation after stock flatlines, no one talking. * **Exit Zone:** Spike tied to war/cyber headlines or sudden contract PR hype. * **Rule:** Never treat CTM as a long-term compounding asset. It is a “security cosplay” ticker. Your role = extract when others confuse cosplay for castle.

Mentions:#PR#CTM

Seems to be getting alot of PR also! I’m not in it yet but I may start out by selling puts…. Or choose a 30-90 day call to buy…. Hmm?

Mentions:#PR

Surprised nobody mentioned **$TNFA** for premarket, 30% short, fluff AH PR followed by spike AH. Watch volume for continuation. Nothing crazy but might run more before coming back down. NFA I have a sell order in at 0.14

Mentions:#TNFA#PR

There has to be an explosive PR coming for OPEN tomorrow for RH to create a pre-emptive circuit breaker that restricts buying at midnight…

Mentions:#PR#OPEN

P/S on this shitstock is still above 110. Most don’t realize what this means and how inane that kind of valuation is! And no Palantir is not an AI company, it merely makes API calls to AI services for data analytics purposes. The only thing it’s got going is government contracts thanks to under the table bribery of government officials, and the insane PR marketing tactics by alex karp and his marketing gang.

Mentions:#API#PR

https://x.com/ameliamaya98/status/1957795395049799692 Long thread about S3. I feel something is so bound to happen. I'm in on medical research companies, though mine (IGC) are hosting trials in PR, Canada, and in some states that are more aligned with medical programs. Don't have any in TLRY right now, but could move to it.

Mentions:#IGC#PR#TLRY

Agreed, something happened for sure but hopefully it will correct. Still no shares available and ctb keeps climbing. Good PR could send it flying for sure

Mentions:#PR

They were planning to have pre-sNDA meeting on 20th but they cancelled it, as they provided all the needed info for FDA already. BTAI announced today that they locked the data. It normally takes 1-3 weeks to analyse and release the results, but they said in today’s PR that it will be available during August.

Mentions:#BTAI#PR

Didn’t they have a good PR today?

Mentions:#PR

No, but they operate like one, is what I mean. Zero PR, no earnings call, they just drop earnings report on random dates. No social media accounts, nothing. Retail just have to wait on their knees for any updates. They have ties to the govt, but nothing seems to come out of it yet. No contract announcement for 8 months is insane. To add salt to the wound, couple insiders sold a total of 1M shares at low prices. The reports which were released had plenty of errors in them, which shows lack of attention to detail. All the gains from the past 3 months were erased now.. Miraculously, this company could do something big if they release contracts, but why stick with this company when there are so many better performing ones like AMPX, ONDS etc.

Mentions:#PR#AMPX#ONDS

You’re going to hold this call to zero. Just watch. PLTR was pumped up via PR stunts by Alex and his marketing team.

Mentions:#PLTR#PR

It’s going to 40 first, then to 20, then 10. PLTR is the most bs company out there. They pumped their stock via PR stunts while being a simple data analytics company. It’s not an AI company, simply makes calls to AI APIs.

Mentions:#PLTR#PR

ZENA had some good PR earlier. Naturally it’s dipping now

Mentions:#ZENA#PR

Follow ups for today:  - GIBO (reverse split tomorrow, expecting a rise before the effective split) - FLYE: dropped 88% on friday because someone said this is a pump and dump stock. Bought some shares with an average of 1.07, I see this rising again of they release a decent PR. NFA

Mentions:#FLYE#PR

I sold as soon as it hit $25. You were not wrong. This was just unexpected. Now I am buying puts. Having a bunch of cash won't help Intel and there will be more dark days and mass layoffs before things get better. Not until 3rd parties start announcing fab agreements -- and I mean commitments, not just PR -- will it matter.

Mentions:#PR

**$ADD** : See this one thrown around careful with FOMO, it’s up 50% AH on 6K finalized dilution, I entered at 0.089 will exit at 0.15-0.17 realistically PM : AH SEC filling : https://www.sec.gov/Archives/edgar/data/1747661/000121390025078020/ea0253553-6k_color.htm **$LASE** : PM Watchlist short swing (67% AH) - PR(Aug-18 AH) : https://finviz.com/news/143601/laser-photonics-reports-q2-2025-revenue-growth-of-317-year-over-year . Still in **$SCNI** until EOM, waiting for Pincell acquisition PR, 10% SL.

CELZ - possible pop today, expected them to release PR on patent news. Usually hit or miss, low float and if volume come it will pop

Mentions:#CELZ#PR

Being 100% honest, new CEO is big on share price. After todays two PR’s (Mash + ozempic price cut) hes gonna pull a quick one and announce layoffs really soon. Cutting costs and hoping on a volume game with goodRx. Its gonna jump.

Mentions:#PR

Nah. I would be money that they do annual raises typically towards the end of their fiscal year, which is the end of September. These 2% raises are what they are getting and they are trying to spin it as positive PR.

Mentions:#PR

Doesnt matter, too many tailwinds. IF interest rates are cut, then they are done. This is not for short term obviously, I am holding long. We are seeing big investors coming in with lots of PR. No way they will let this drop.

Mentions:#PR

CGTX may get some PR Thursday to boost it a little. But even if treads water all week, it will rocket next Monday. That is NASDAQ compliance day and I'm pretty sure some tutes will jump on it after that.

Mentions:#CGTX#PR

Looked into it. The thing that worries me most is credibility. A lot of the flashy numbers you see (the cash pile, the bitcoin stash, the big contracts) come straight from company press releases and get repeated around without much verification. But if you look at their actual SEC filings, you see a very different story: multiple reverse splits, big shelf offerings, and new convertible financing. They’ve even admitted to weaknesses in their internal controls, and because they use Nasdaq’s home country exemptions, they don’t need shareholder approval to issue a ton of new stock. That’s why dilution risk is so high here. Same with the bitcoin and cash. The company itself only talks about a $200M program in bitcoin and derivatives, not necessarily coins they’re holding in cold storage. And the cash balance is all over the place depending on which filing or PR you look at, with the added wrinkle that some of that money might be locked up in their China-based subsidiaries.

Mentions:#PR